Stat3 and G-CSF-induced myeloid differentiation
- PMID: 9711905
- DOI: 10.3109/10428199809057555
Stat3 and G-CSF-induced myeloid differentiation
Abstract
Granulocyte colony-stimulating factor (G-CSF) is the cytokine critical for directing neutrophilic granulocyte differentiation. Early G-CSF signaling events in myeloid cells involves activation of STATs, proteins that serve the dual function of signal transduction and activation of transcription, especially the activation of Stat3. A dominant-negative mutant construct of Stat3 inhibited G-CSF-mediated neutrophilic differentiation indicating that Stat3 is a essential component for driving the G-CSF-mediated differentiation program in myeloid cells. Three isoforms of Stat3 have been identified, alpha(p92), beta(p83) and gamma(p72) each derived from a single gene. Stat3alpha is the predominant isoform expressed in most cells. Stat3beta is derived from Stat3alpha by alternative RNA splicing. Stat3gamma is derived from Stat3alpha by limited proteolysis. Mapping of Stat3alpha and Stat3beta activation in M1 murine myeloid leukemia cells revealed that their optimal activation required G-CSFR constructs containing both Y704 and Y744. These amino acid residues has previously been demonstrated to be essential for G-CSF-induced differentiation in this cells. Phosphopeptide affinity and phosphopeptide inhibition studies indicate that Stat3alpha and Stat3beta are recruited to the G-CSF receptor complex through their interaction with the receptor at phosphotyrosines Y704 and Y744. Y744 is followed at the +3 position by Cys (C). This sequence YXXC, represents a novel motif implicated in the recruitment and activation of Stat3alpha, Stat3beta and Stat3gamma by the hG-CSFR. Structurally, Stat3alpha, Stat3beta and Stat3gamma differ from each other in their C-terminal transactivation domain. In the beta isoform, the Stat3alpha transactivation domain is replaced by 7 amino acid residues which enable Stat3beta to interact with c-Jun. In the gamma isoform, the Stat3alpha transactivation domain is removed by limited proteolysis creating a dominant negative isoform. In immature human myeloid cells capable of differentiating into neutrophils in response to G-CSF, G-CSF did not activate Stat3alpha; rather. it activated predominantly Stat3beta. These findings combined with recent reports linking Stat3alpha with proliferation and transformation suggest that the beta isoform of Stat3 may be more critical for G-CSF-mediated differentiation. Activation of Stat3gamma occurred predominantly in terminally differentiated neutrophils suggesting that it may be part of a controlled proteolytic mechanism modulating pro-proliferative protein(s) in mature myeloid cells.
Similar articles
-
Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor.Blood. 1999 Jan 1;93(1):15-24. Blood. 1999. PMID: 9864141
-
STAT3beta does not interfere with granulocyte colony-stimulating factor-induced neutrophilic differentiation.Hematol J. 2000;1(4):220-5. doi: 10.1038/sj.thj.6200041. Hematol J. 2000. PMID: 11920194
-
Granulocyte colony-stimulating factor activates a 72-kDa isoform of STAT3 in human neutrophils.J Leukoc Biol. 1998 Nov;64(5):675-80. doi: 10.1002/jlb.64.5.675. J Leukoc Biol. 1998. PMID: 9823774
-
STAT3beta, a distinct isoform from STAT3.Int J Biochem Cell Biol. 2019 May;110:130-139. doi: 10.1016/j.biocel.2019.02.006. Epub 2019 Feb 26. Int J Biochem Cell Biol. 2019. PMID: 30822557 Review.
-
Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders.Front Biosci. 2007 Jan 1;12:800-15. doi: 10.2741/2103. Front Biosci. 2007. PMID: 17127321 Review.
Cited by
-
Transcription Factor STAT3 as a Novel Molecular _target for Cancer Prevention.Cancers (Basel). 2014 Apr 16;6(2):926-57. doi: 10.3390/cancers6020926. Cancers (Basel). 2014. PMID: 24743778 Free PMC article.
-
Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.Clin Cancer Res. 2006 Nov 15;12(22):6817-25. doi: 10.1158/1078-0432.CCR-06-1354. Clin Cancer Res. 2006. PMID: 17121903 Free PMC article.
-
Selective activation of STAT3 and STAT5 dictates the fate of myeloid progenitor cells.Cell Death Discov. 2023 Jul 28;9(1):274. doi: 10.1038/s41420-023-01575-y. Cell Death Discov. 2023. PMID: 37507383 Free PMC article.
-
STAT4 isoforms differentially regulate Th1 cytokine production and the severity of inflammatory bowel disease.J Immunol. 2008 Oct 1;181(7):5062-70. doi: 10.4049/jimmunol.181.7.5062. J Immunol. 2008. PMID: 18802110 Free PMC article.
-
Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors.Oncol Lett. 2020 Apr;19(4):2585-2594. doi: 10.3892/ol.2020.11394. Epub 2020 Feb 13. Oncol Lett. 2020. PMID: 32218808 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous